subject: Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD) [print this page] Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD)
TheChronic Obstructive Pulmonary Disease (COPD) Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the COPD market, as well as sales of leading drugs and therapies are provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and TherapyReview provides a conciseanalysis of the most important informationabout a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategiesand treatment options, general information about the market size, and information about important market trends. Thedata contained in these reportscomes fromkey industry secondary data sources,such astheTimely Data ResourcesIncidence and Prevalence Database, andLange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites.Sources and references are provided.
I.OVERVIEW
General description of the condition
II.INCIDENCE AND PREVALENCE
Prevalence Table (US, Canada, Mexico, UK, France, Germany, Italy, Spain, Japan, China, India, Australia, Worldwide)
